ARK Genomic Revolution ETF (BATS:ARKG) Sets New 1-Year High – Here’s What Happened

ARK Genomic Revolution ETF (BATS:ARKG) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $49.96 and last traded at $49.85, with a volume of 1372721 shares changing hands. The stock had previously closed at $48.01.

ARK Genomic Revolution ETF Price Performance

The stock has a 50 day moving average of $41.69 and a 200-day moving average of $33.85.

Hedge Funds Weigh In On ARK Genomic Revolution ETF

A number of institutional investors have recently modified their holdings of ARKG. Turner Financial Group Inc. purchased a new stake in ARK Genomic Revolution ETF during the second quarter worth $1,633,000. Continuum Advisory LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the second quarter valued at approximately $76,000. MBA Advisors LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at about $270,000. SkyOak Wealth LLC acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter valued at about $213,000. Finally, Beacon Financial Advisory LLC purchased a new position in ARK Genomic Revolution ETF in the second quarter worth approximately $245,000.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.